All 3 patients were found to carry the same heterozygous deletion of exons 28 and 29 of OPA1. We excluded point mutations in autosomal dominant PD genes via focused exome sequencing in patient P2 (Illumina TruSight One). This evidence concerns the gene OPA1 and Parkinson disease.